The Impact
Why do health screenings for mediscan? Testing for fatty liver disease has been shown to positively impact health
Screening for fatty liver disease encourages healthy behaviors
In a large randomized clinical trial with ~ 5000 participants, screening for fatty liver disease led to 35% improvement in diet, 22% increase in exercise and 13% decrease in weight loss (>5%) in participating patients.
Screening for fatty liver disease with lifestyle management is effective for weight loss.
In a community based randomized control trial, screening for fatty liver disease followed up with a lifestyle modification programme led to a 64% reversal in MASLD and on average a 5.6 kg decrease in weight.
Screening for fatty liver disease effective in reducing bad habits
In an intervention screening trial for alcohol addicted patients, fatty liver disease screening with a lifestyle intervention program led to a 26% increase in alcohol abstinence compared to controls and overall 45% abstained from alcohol.
Watch here on how mediscan fatty liver screening positively impacts making healthy decisions within the community
Kjaergaard et al. Clinical Gastroenterology and Hepatology 22.5 (2024): 1037-1047.
Wong et al. Journal of Hepatology 59.3 (2013): 536-542.
Avitabile et al. JHEP Reports (2024): 101165.